Christina Wu, MD

Christina Wu

College

College of Medicine

Division/Department

Internal Medicine

Academic Title

Asst Professor - Clinical

Research Program

Molecular Biology and Cancer Genetics

Research Interest

Colorectal Neoplasms, Neoplasm Metastasis, Colonic Neoplasms, Colorectal Neoplasms, Hereditary Nonpolyposis, Central Nervous System Neoplasms, Neoplasms, Nausea, Pancreatic Neoplasms, fatigue, Neoplasm Recurrence, Local

Dr. Wu’s research involves both translational and clinical studies. She is the co-principal investigator of a phase I clinical trial of trametinib, a MEK inhibitor, in combination with neoadjuvant chemoradiation in rectal cancers that have either KRAS, NRAS, or BRAF mutation, and the principal investigator of a phase II clinical trial of panitumumab and chemotherapy in patients with advanced KRAS wild-type colorectal cancer after prior therapy with bevacizumab. Pre-clinical research projects include analyzing colorectal cancer tumors that carry microsatellite instable characteristics and correlating those features with survival and treatment efficacy. Another research project she is currently involved in is titled ”Therapeutic Targeting KRAS Mutation-Driven Tumor Progression and Liver Metastasis in Colorectal Cancer.”


Education and Background

Education

  • B.A., Washington University

    St. Louis, MO (USA)

  • M.D., University of Dublin

    Dublin, Ireland (Irelan)

Residencies

  • Internal Medicine Residency

    University of Massachusetts

    Worcester, MA (USA)

  • Transitional Year Residency

    St. Vincent’s Medical Center

    Bridgeport, CT (USA)

Fellowship

  • Hematology/Oncology Fellowship

    Lombardi Comprehensive Cancer Center Georgetown University Hospital

    Washington, D.C.

  • Postdoctoral Research Fellowship

    Boston University School of Medicine

    Boston, MA (USA)

Office Locations

Starling Loving Hall

320 W 10th Avenue, Columbus, Ohio 43210


614-293-7520



Publications

Back to Researcher Search